Upgrade to SI Premium - Free Trial

Pfizer (PFE) Surges 8%, Merck (MRK) Down 5% Following Pfizer's COVID-19 Oral Antiviral Treatment Data

November 5, 2021 6:49 AM

Pfizer (NYSE: PFE) Surges 8%, Merck (NYSE: MRK) Down 5% Following Pfizer's COVID-19 Oral Antiviral Treatment Data

Categories

Corporate News Hot Corp. News Trader Talk

Next Articles